Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Christopher Carlson
Fred Hutchinson Cancer Research Center, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Adpative Biotechnologies Corporation
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Please see the attached response.
Monitoring disease progression in follicular lymphoma with next-gen sequencing
Follicular lymphoma is a common cancer in elderly Americans, diagnosed in approximately 14,000 patients annually. Recent therapeutic advances in treatment of follicular lymphoma have improved average survival, but it remains an incurable disease. We propose to apply a novel diagnostic system that we have developed, to identify and detect DNA sequences that are biomarkers for follicular lymphoma tumors. If successful, then application of our diagnostic tools should improve follicular lymphoma patient outcomes, while improving the cost effectiveness of existing follicular lymphoma treatments by focusing these therapies on early treatment of the highest risk patients.
Filed on April 14, 2015.
Tell us what you know about Christopher Carlson's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Christopher Carlson filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Christopher Carlson | Fred Hutchinson Cancer Research Center | Conflict of Interest | Adpative Biotechnologies Corporation | $40,000 - $59,999 |
| Christopher Carlson | Fred Hutchinson Cancer Research Center | Conflict of Interest | Adpative Biotechnologies Corporation | Value cannot be readily determined |
| Christopher Carlson | Fred Hutchinson Cancer Research Center | Conflict of Interest | Adpative Biotechnologies Corporation | Value cannot be readily determined |
| Christopher Carlson | Fred Hutchinson Cancer Research Center | Conflict of Interest | Adpative Biotechnologies Corporation | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.